Skip to main content
. 2005 Nov 15;107(5):1785–1790. doi: 10.1182/blood-2004-09-3501

Table 3.

Joint bleeding episodes and factor replacement usage

6-wk base study
6-mo extension study
Placebo Etoricoxib 90 mg Rofecoxib 25 mg Etoricoxib 90 mg
Joint bleeding episodes, no. of patients (%) 37 (72.6) 34 (66.7) 15 (78.9) 57 (77.0)
Factor use for joint bleeding episodes, no. of patients (%) 35 (68.6) 33 (64.7) 15 (78.9) 56 (75.7)